EDGC made an announcement on the 14th that its affiliate, EDGC Healthcare supplied its first and second batch of diagnostic reagents for COVID-19 to SYNLAB in Europe, followed by a third supply. The supply contract is worth 1.3 billion won.

SYNLAB is a leading provider of laboratory diagnostic services based in Germany with annual sales of about 1.9 billion euros (about 2.6 trillion won) as of 2017 around Europe. The laboratory currently operates a total of 42 branches in 34 European countries, Middle East and South America, provides more than 500 million testing services annually to medical institutions including general hospitals and small check-up centers.